Howe & Rusling’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-54
| Closed | -$1K | – | 323 |
|
|
2022
Q3 | $1K | Sell |
54
-50
| -48% | -$926 | ﹤0.01% | 933 |
|
|
2022
Q2 | $1K | Buy |
104
+45
| +76% | +$433 | ﹤0.01% | 920 |
|
|
2022
Q1 | $1K | Hold |
59
| – | – | ﹤0.01% | 905 |
|
|
2021
Q4 | $1K | Sell |
59
-39
| -40% | -$661 | ﹤0.01% | 901 |
|
|
2021
Q3 | $2K | Buy |
98
+33
| +51% | +$673 | ﹤0.01% | 825 |
|
|
2021
Q2 | $2K | Hold |
65
| – | – | ﹤0.01% | 771 |
|
|
2021
Q1 | $2K | Sell |
65
-4,665
| -99% | -$144K | ﹤0.01% | 770 |
|
|
2020
Q4 | $253K | Hold |
4,730
| – | – | 0.04% | 150 |
|
|
2020
Q3 | $195K | Hold |
4,730
| – | – | 0.03% | 152 |
|
|
2020
Q2 | $229K | Hold |
4,730
| – | – | 0.04% | 127 |
|
|
2020
Q1 | $200K | Buy |
4,730
+1,900
| +67% | +$80.3K | 0.04% | 139 |
|
|
2019
Q4 | $121K | Hold |
2,830
| – | – | 0.02% | 223 |
|
|
2019
Q3 | $102K | Hold |
2,830
| – | – | 0.02% | 238 |
|
|
2019
Q2 | $76K | Hold |
2,830
| – | – | 0.01% | 259 |
|
|
2019
Q1 | $76K | Hold |
2,830
| – | – | 0.01% | 251 |
|
|
2018
Q4 | $46K | Hold |
2,830
| – | – | 0.01% | 266 |
|
|
2018
Q3 | $59K | Hold |
2,830
| – | – | 0.01% | 251 |
|
|
2018
Q2 | $43K | Hold |
2,830
| – | – | 0.01% | 270 |
|
|
2018
Q1 | $64K | Hold |
2,830
| – | – | 0.01% | 254 |
|
|
2017
Q4 | $85K | Hold |
2,830
| – | – | 0.02% | 250 |
|
|
2017
Q3 | $107K | Hold |
2,830
| – | – | 0.02% | 237 |
|
|
2017
Q2 | $79K | Buy |
+2,830
| New | +$79K | 0.02% | 225 |
|